Literature DB >> 9624583

Association of phenotypic changes in B cell lymphocytes and plasma viral load in human immunodeficiency virus-infected patients.

M R Dawood1, B Conway, P Patenaude, F Janmohamed, J S Montaner, M V O'Shaughnessy, G W Hammond.   

Abstract

Many B cell abnormalities have been reported in human immunodeficiency virus (HIV)-infected patients, including changes in the expression of mu, gamma, and CD22 molecules on the cell surface. Phenotypic changes in these markers on B cells isolated from HIV-seropositive patients with high or low levels of plasma viremia were measured. The phenotypic changes in B cells isolated from such patients were compared with the markers on B cells isolated from HIV-seronegative individuals using three-color flow cytometry. HIV patients showed a reduction in the proportion of mature B cells isolated from peripheral blood mononuclear cells compared with B cells isolated from HIV-seronegative individuals. An increase in the proportion of B cells expressing both mu and gamma molecules on the cell surface was also seen in association with high-HIV plasma viremia. A low plasma viral load was accompanied by a reduction in the proportion of B cells expressing both mu and gamma molecules to a level comparable to those seen in HIV-seronegative individuals. HIV-seropositive individuals demonstrated an increase in the proportion of committed B cells, as indicated by an increase in the proportion of B cells expressing gamma molecules. This observation may explain the poor humoral response of HIV seropositive patients to neo-antigens. Our results demonstrate that phenotypic changes indicative of in vivo B cell activation and an increase in immature cells are associated with HIV infection, particularly with a high plasma viral load. Phenotypic changes in B cell markers may correlate with functional deficits of B cells.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9624583     DOI: 10.1023/a:1020539207593

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  24 in total

1.  A new method for detachment of Dynabeads from positively selected B lymphocytes.

Authors:  A M Rasmussen; E B Smeland; B K Erikstein; L Caignault; S Funderud
Journal:  J Immunol Methods       Date:  1992-02-05       Impact factor: 2.303

Review 2.  B-cell activation and HIV-1 infection: deeds and misdeeds.

Authors:  A Amadori; L Chieco-Bianchi
Journal:  Immunol Today       Date:  1990-10

Review 3.  Antibody responses in HIV infection.

Authors:  A J Pinching
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

Review 4.  B cell responses to HIV and the development of human monoclonal antibodies.

Authors:  J E Boyd; K James
Journal:  Clin Exp Immunol       Date:  1992-05       Impact factor: 4.330

5.  HIV-1-specific B cell activation. A major constituent of spontaneous B cell activation during HIV-1 infection.

Authors:  A Amadori; R Zamarchi; V Ciminale; A Del Mistro; S Siervo; A Alberti; M Colombatti; L Chieco-Bianchi
Journal:  J Immunol       Date:  1989-10-01       Impact factor: 5.422

6.  Poor antibody response after tetanus and pneumococcal vaccination in immunocompromised, HIV-infected patients.

Authors:  M Opravil; W Fierz; L Matter; J Blaser; R Lüthy
Journal:  Clin Exp Immunol       Date:  1991-05       Impact factor: 4.330

7.  Defective B-lymphocyte function in homosexual men in relation to the acquired immunodeficiency syndrome.

Authors:  S G Pahwa; M T Quilop; M Lange; R N Pahwa; M H Grieco
Journal:  Ann Intern Med       Date:  1984-12       Impact factor: 25.391

8.  Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome.

Authors:  H C Lane; H Masur; L C Edgar; G Whalen; A H Rook; A S Fauci
Journal:  N Engl J Med       Date:  1983-08-25       Impact factor: 91.245

9.  Antibody response to measles and rubella vaccine by children with HIV infection.

Authors:  A E Breña; E R Cooper; H J Cabral; S I Pelton
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1993-10

10.  Nonrandom development of immunologic abnormalities after infection with human immunodeficiency virus: implications for immunologic classification of the disease.

Authors:  S Zolla-Pazner; D C Des Jarlais; S R Friedman; T J Spira; M Marmor; R Holzman; D Mildvan; S Yancovitz; U Mathur-Wagh; J Garber
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

View more
  3 in total

Review 1.  Immune activation and HIV persistence: implications for curative approaches to HIV infection.

Authors:  Nichole R Klatt; Nicolas Chomont; Daniel C Douek; Steven G Deeks
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

2.  Combination exposure to zidovudine plus sulfamethoxazole-trimethoprim diminishes B-lymphocyte immune responses to Pneumocystis murina infection in healthy mice.

Authors:  David J Feola; Beth A Garvy
Journal:  Clin Vaccine Immunol       Date:  2006-02

3.  Characterising B cell numbers and memory B cells in HIV infected and uninfected Malawian adults.

Authors:  Herbert Longwe; Stephen Gordon; Rose Malamba; Neil French
Journal:  BMC Infect Dis       Date:  2010-09-22       Impact factor: 3.090

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.